Atlas Trials

" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "

Clinical trial NCT05580510 · UNKNOWN

Trial details

NCT number
NCT05580510
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Congenital Heart DiseaseHeart FailureHeart Failure With Reduced Ejection Fraction
Start date
2023-02-06
Primary completion
2023-07-28
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.